Oppenheimer Initiates Coverage Of Lannett At Outperform, $7 PT (LCI)

by Benzinga Staff
March 30, 2011 7:33 AM | 6 seconds read |
Oppenheimer initiates coverage of Lannett LCI at an Outperform rating with a $7 Price Target.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Price TargetInitiationAnalyst RatingsHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!